Cargando…
Mutant prevention concentration of orbifloxacin: comparison between Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus pseudintermedius of canine origin
BACKGROUND: The mutant prevention concentration (MPC) is an important parameter to evaluate the likelihood of growth of fluoroquinolone-resistant mutants for antimicrobial-pathogen combinations. The MPCs of fluoroquinolones for different canine pathogens have not been compared. In this study, we com...
Autores principales: | Shimizu, Takae, Harada, Kazuki, Kataoka, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646708/ https://www.ncbi.nlm.nih.gov/pubmed/23634902 http://dx.doi.org/10.1186/1751-0147-55-37 |
Ejemplares similares
-
Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs
por: Harada, Kazuki, et al.
Publicado: (2012) -
Effects of oral orbifloxacin on fecal coliforms in healthy cats: a pilot
study
por: HARADA, Kazuki, et al.
Publicado: (2015) -
A pharmacodynamic investigation to assess the synergism of orbifloxacin and propyl gallate against Escherichia coli
por: Abbas, Muhammad Aleem, et al.
Publicado: (2022) -
The Complex Diseases of Staphylococcus pseudintermedius in Canines: Where to Next?
por: Lynch, Stephanie A., et al.
Publicado: (2021) -
From canines to humans: Clinical importance of Staphylococcus pseudintermedius
por: Carroll, Karen C., et al.
Publicado: (2021)